Pharmaceutical giant Gilead Sciences has agreed to donate drugs that reduce the risk of HIV transmission for up to 200,000 people a year, the Trump administration says.
The agreement between Gilead and the Trump administration will last until at least Dec. 31, 2025, and possibly through the end of 2030, Health and Human Services Secretary Alex Azar said in a statement Thursday. Gilead will donate its PrEP medication Truvada, which is used to reduce the risk of HIV infection and usually sells for $1,600 to $2,000 a month in the United States.
The deal will “help us achieve our goal of ending the HIV epidemic in America!,” President Donald Trump said in a tweet.
About the Author
Breaking News! Developing Story! Team Coverage! ..14 August 1996.. Loco men and their OffSpring go on Rampage breaking glass, pulling…
Matthew 6:24 24 “No one can serve two masters. Either you will hate the one and love the other, or…
Light bulbs and 'coke-heads' burn out, batteries discharge.
Your weak attempt falls flat on it's face. 30 years ago they would have been destroyed by local men and…
earn baby earn. you want it? you have to own it or buy it. this is America. make jokes about…